Dr Reddys Laboratories Share Price Today - Live Blog for October 15, 2025

Dr Reddys Laboratories Ltd witnessed a -0.07% decrease in its share price, and it is currently trading at ₹1,231.80. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 17.9800, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

After a significant 0.08% gain, Dr Reddys Laboratories Ltd's shares are now valued at ₹1,232.55 in the current market. This upward movement is attracting attention from both retail and institutional investors.

After a -0.04% decline, Dr Reddys Laboratories Ltd shares are now trading at ₹1,232.50. The stock has a PE ratio of 17.9800, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.26%, reaching a current market price of ₹1,232.90. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.10%, reaching a current market price of ₹1,235.70. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

With a -0.14% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,236.90. The stock is currently trading at a PE of 17.9800, while the industry PE is 34.9845, prompting investors to assess its value proposition.

Dr Reddys Laboratories Ltd experienced a -0.10% dip in its share price and is currently trading at ₹1,238.60. The stock has a PE ratio of 17.9800, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 0.14%, reaching the current market price of ₹1,239.90. This ascent signifies increased investor sentiment. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

Investors are buzzing as Dr Reddys Laboratories Ltd's share price soared by an impressive 0.06%. At this moment, it's actively trading at ₹1,238.20, presenting an enticing opportunity for those in the market.

Dr Reddys Laboratories Ltd experienced a -0.04% dip in its share price and is currently trading at ₹1,235.65. The stock has a PE ratio of 17.9800, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd shares saw a -0.04% decrease, reaching a current market price of ₹1,235.65. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 17.9800, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.01% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,236.20 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.15% drop, and it's now trading at ₹1,235.55 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

Dr Reddys Laboratories Ltd's share price has experienced a notable 0.02% upswing, and it's currently trading at ₹1,236.45 per share. Investors are closely watching this development.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.16%, signalling a challenging period. Currently trading at ₹1,236.20, this stock has caught the eye of bargain hunters, who may be considering their entry points.

Demonstrating a commendable 0.01% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,238.10. In terms of valuation, the stock maintains a PE ratio of 17.9800, while the industry PE ratio stands at 34.9845.

Dr Reddys Laboratories Ltd shares experienced a -0.06% reduction, with the current market price at ₹1,238.00. Investors are carefully considering their positions and seeking insights into the stock's future performance.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.04% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,239.25 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

The share price of Dr Reddys Laboratories Ltd recently experienced a positive upturn, resulting in a 0.02% increase. Presently, it is actively trading at ₹1,239.90.

Dr Reddys Laboratories Ltd witnessed a substantial 0.02% increase in its share price and is currently trading at ₹1,239.90. This remarkable performance has caught the eye of investors.

In the financial arena, Dr Reddys Laboratories Ltd's stock price has increased by 0.02%, with its current market value per share resting at ₹1,239.90. This development highlights the stock's appeal to investors.

Dr Reddys Laboratories Ltd observed a remarkable 0.08% surge in its share price and is presently trading at ₹1,239.00. The increased investor interest is driving this surge.

Dr Reddys Laboratories Ltd's share price has fallen by -0.18%, a situation worth noting. At present, the stock is trading at ₹1,238.00. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 17.9800, while the industry PE ratio is 34.9845.

Dr Reddys Laboratories Ltd experienced a -0.07% downturn in its share price, and it's currently trading at ₹1,239.65. This situation is generating interest among value investors who are evaluating the stock's potential.

Dr Reddys Laboratories Ltd's share price remained unchanged, indicating a period of stability in the market. As of now, the stock is still trading at ₹1,240.50. This static phase might encourage investors to assess their long-term strategies.

Dr Reddys Laboratories Ltd's stock price surged by 0.32%, reaching the current market value of ₹1,240.50 per share. This surge is a testament to the stock's recent performance.

The stock of Dr Reddys Laboratories Ltd suffered a -0.03% drop, and it's now trading at ₹1,237.60 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.